Serial Number | 90285295 |
Word Mark | 3RDEYEBIO |
Filing Date | Wednesday, October 28, 2020 |
Status | 700 - REGISTERED |
Status Date | Tuesday, March 22, 2022 |
Registration Number | 6675095 |
Registration Date | Tuesday, March 22, 2022 |
Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, January 4, 2022 |
Description of Mark | The mark consists of the stylized wording "3RDEYEBIO" with an incomplete, shaded letter "O" outlined with a single lined circle with four protruding diagonal lines from the circle and each connected to smaller shaded circles of varying sizes, forming a molecular model design. The background is for shading purposes only and is not claimed as a feature of the mark. |
Pseudo Mark | THIRD EYE BIO |
Goods and Services | Investor development and management in the nature of business intermediary services relating to the matching of potential private investors with entrepreneurs needing funding; Advisory board development and management being personnel management services; Regulatory compliance development and management in the nature of regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies |
Goods and Services | Research and development in the pharmaceutical and biotechnology fields, Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Biochemical research and development; Conducting clinical trials for others; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Medical research services in the field of cancer; Pharmaceutical research and development; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Providing a website featuring educational information in the field of clinical research; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical testing services and information in the field of cancer research and disease classification; Scientific research and development; Scientific and technological services, namely, research and design in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and acute and chronic devastating diseases and conditions beyond cancer; Stem cell research services; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Monday, December 28, 2020 |
Primary Code | 035 |
First Use Anywhere Date | Sunday, March 1, 2020 |
First Use In Commerce Date | Sunday, March 1, 2020 |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, December 28, 2020 |
Primary Code | 042 |
First Use Anywhere Date | Sunday, March 1, 2020 |
First Use In Commerce Date | Sunday, March 1, 2020 |
Party Name | 3RDEYEBIO LLC |
Party Type | 30 - Original Registrant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Seattle, WA 98115 |
Party Name | 3RDEYEBIO LLC |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 16 - Limited Liability Company |
Address | Seattle, WA 98115 |
Party Name | 3RDEYEBIO LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Seattle, WA 98115 |
Event Date | Event Description |
Tuesday, March 22, 2022 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, January 4, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, January 4, 2022 | PUBLISHED FOR OPPOSITION |
Wednesday, December 15, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, December 1, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, December 1, 2021 | EXAMINER'S AMENDMENT ENTERED |
Wednesday, December 1, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Wednesday, December 1, 2021 | EXAMINERS AMENDMENT E-MAILED |
Wednesday, December 1, 2021 | EXAMINERS AMENDMENT -WRITTEN |
Thursday, July 1, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Thursday, July 1, 2021 | LETTER OF SUSPENSION E-MAILED |
Thursday, July 1, 2021 | SUSPENSION LETTER WRITTEN |
Tuesday, June 1, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, June 1, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, June 1, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Saturday, April 3, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Saturday, April 3, 2021 | NON-FINAL ACTION E-MAILED |
Saturday, April 3, 2021 | NON-FINAL ACTION WRITTEN |
Monday, March 29, 2021 | ASSIGNED TO EXAMINER |
Tuesday, December 29, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Monday, December 28, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Sunday, November 1, 2020 | NEW APPLICATION ENTERED IN TRAM |